Literature DB >> 19165571

Naxos disease presenting with ventricular tachycardia and troponin elevation.

George Lazaros1, Aris Anastasakis, Dimitris Tsiachris, Polychronis Dilaveris, Nikos Protonotarios, Christodoulos Stefanadis.   

Abstract

Naxos disease is a recessively inherited stereotype association of arrhythmogenic cardiomyopathy with a cutaneous phenotype, characterized by peculiar woolly hair and palmoplantar keratoderma. The cardiomyopathy clinically manifests by adolescence and the symptomatic presentation is usually with syncope and/or sustained ventricular tachycardia of left bundle branch block configuration. We report the case of a 43-year-old man without any history of heart disease who was admitted to the hospital because of an episode of sustained ventricular tachycardia and troponin I elevation, in the absence of coronary artery disease. Diagnostic workup, including genetic assessment, revealed Naxos disease as the underlying cause. In this case, acute myocarditis seems to be the most plausible explanation for the nonischemic myocardial injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19165571     DOI: 10.1007/s00380-008-1082-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  13 in total

1.  Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Giuseppe Boriani; Paolo Artale; Mauro Biffi; Cristian Martignani; Lorenzo Frabetti; Cinzia Valzania; Igor Diemberger; Matteo Ziacchi; Matteo Bertini; Claudio Rapezzi; Mario Parlapiano; Angelo Branzi
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

Review 2.  The arrhythmogenic right ventricle. Dysplasia versus cardiomyopathy.

Authors:  G Fontaine; F Fontaliran; F R Andrade; E Velasquez; J Tonet; X Jouven; Y Fujioka; R Frank
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

3.  In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy.

Authors:  M Valente; F Calabrese; G Thiene; A Angelini; C Basso; A Nava; L Rossi
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).

Authors:  G McKoy; N Protonotarios; A Crosby; A Tsatsopoulou; A Anastasakis; A Coonar; M Norman; C Baboonian; S Jeffery; W J McKenna
Journal:  Lancet       Date:  2000-06-17       Impact factor: 79.321

5.  Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin.

Authors:  N Protonotarios; A Tsatsopoulou; A Anastasakis; E Sevdalis; G McKoy; K Stratos; K Gatzoulis; K Tentolouris; C Spiliopoulou; D Panagiotakos; W McKenna; P Toutouzas
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

6.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Eur Heart J       Date:  2006-09       Impact factor: 29.983

7.  Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy.

Authors:  A Nava; B Bauce; C Basso; M Muriago; A Rampazzo; C Villanova; L Daliento; G Buja; D Corrado; G A Danieli; G Thiene
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

8.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

9.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

10.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

View more
  2 in total

1.  Electrical storm originating from a left ventricular epicardial scar in a patient with completely normal endocardial voltage.

Authors:  Eduardo Back Sternick; Christopher Piorkowski; Gerhard Hindricks; Nikolaos Dagres; Philipp Sommer
Journal:  Heart Vessels       Date:  2011-01-28       Impact factor: 2.037

2.  Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review.

Authors:  Babken Asatryan; Angeliki Asimaki; Andrew P Landstrom; Mohammed Y Khanji; Katja E Odening; Leslie T Cooper; Francis E Marchlinski; Anna R Gelzer; Christopher Semsarian; Tobias Reichlin; Anjali T Owens; C Anwar A Chahal
Journal:  Circulation       Date:  2021-11-15       Impact factor: 39.918

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.